Literature DB >> 22095255

Oxaliplatin in the adjuvant treatment of colon cancer.

Mary Kay Barton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22095255     DOI: 10.3322/caac.21131

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


× No keyword cloud information.
  4 in total

1.  Overexpression of long non-coding RNA colon cancer-associated transcript 2 is associated with advanced tumor progression and poor prognosis in patients with colorectal cancer.

Authors:  Junling Zhang; Yong Jiang; Jing Zhu; Tao Wu; Ju Ma; Chuang Du; Shanwen Chen; Tengyu Li; Jinsheng Han; Xin Wang
Journal:  Oncol Lett       Date:  2017-09-25       Impact factor: 2.967

2.  Overexpression of Rab1B and MMP9 predicts poor survival and good response to chemotherapy in patients with colorectal cancer.

Authors:  Xian-Zi Yang; Shu-Zhong Cui; Li-Si Zeng; Tian-Tian Cheng; Xiao-Xing Li; Jun Chi; Ren Wang; X F Steven Zheng; Hui-Yun Wang
Journal:  Aging (Albany NY)       Date:  2017-03-18       Impact factor: 5.682

3.  Association between glioblastoma cell-derived vessels and poor prognosis of the patients.

Authors:  Xin Mei; Yin-Sheng Chen; Qing-Ping Zhang; Fu-Rong Chen; Shao-Yan Xi; Ya-Kang Long; Ji Zhang; Hai-Ping Cai; Chao Ke; Jing Wang; Zhong-Ping Chen
Journal:  Cancer Commun (Lond)       Date:  2020-05-02

4.  Pharmaceutical immunoglobulin G impairs anti-carcinoma activity of oxaliplatin in colon cancer cells.

Authors:  Yuru Shang; Xianbin Zhang; Lili Lu; Ke Jiang; Mathias Krohn; Stephanie Matschos; Christina Susanne Mullins; Brigitte Vollmar; Dietmar Zechner; Peng Gong; Michael Linnebacher
Journal:  Br J Cancer       Date:  2021-02-09       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.